We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
How to use a before-and-after study to evaluate your digital health product.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Find out more information on expenses, payments and benefits that are non-taxable.
Get help and extra support when dealing with HMRC if you have additional needs - for example you have a disability or health condition, if English is not your first language or if you’re experiencing domestic abuse or financial hardship.
A form of IP that extends the protection of patented active ingredients present in pharmaceutical or plant protection products.
Information on the reporting, investigation and management of acute flaccid paralysis (AFP) and acute flaccid myelitis (AFM).
Guidance primarily aimed at local responders covering some humanitarian issues that may arise during the recovery phase of an emergency in the UK.
Investors and businesses may be legally required to tell the government about certain sensitive acquisitions under the National Security and Investment Act.
How to set what you’ll evaluate digital outcomes, digital specialists, user research participants and studio suppliers on.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
How much PE and sport premium funding schools will receive for the academic year 2023 to 2024 and advice on how to spend it.
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
How to tax a beneficial loan arrangement for a director or employee.
Find out about the rules you must follow for spending, borrowing from, or transferring your charity’s permanent endowment.
Explains planning controls relating to the storage of hazardous substances in England and how to handle development proposals around hazardous establishments.
How to use a cost utility analysis to evaluate your digital health product.
Guidance on who to test for Zika virus infection and which samples to collect.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).